<DOC>
	<DOCNO>NCT01392534</DOCNO>
	<brief_summary>One common adverse effect result therapy thiazide , thiazide-like diuretic loop diuretic increase potassium secretion . Disregulation plasma potassium may life-threatening condition due increase risk arrythmias . Moreover , postulate decrease plasma potassium level may negatively affect glucose metabolism result increase risk new-onset type 2 diabetes.The main goal study assess efficacy safety telmisartan/hydrochlorothiazide broad population hypertensive patient , include effect therapy plasma potassium level also select parameter glucose lipid metabolism .</brief_summary>
	<brief_title>Effects Telmisartan/Hydrochlorothiazide Treatment Hypertensive Patients Under Real-life Setting</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>primary hypertension age &gt; 18 year Cholestatic disorder severe hepatic/renal failure allergy telmisartan hydrochlorothiazide treatmentresistant hypokalemia hypercalcemia pregnancy lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Hydrochlorothiazide</keyword>
	<keyword>Potassium</keyword>
	<keyword>Glucose metabolism</keyword>
	<keyword>Lipid metabolism</keyword>
</DOC>